Article
Lipid-mediated insertion of Toll-like receptor (TLR) ligands for facile immune cell engineering
2019-11-16
Abstract excerpt
Cell-based immunotherapies have tremendous potential to treat many diseases, such as activating immunity in cancer or suppressing it in autoimmune diseases. Most cell-based cancer immunotherapies in the clinic provide adjuvant signals through genetic engineering to enhance T cell functions. However, genetically encoded signals have minimal control over dosing and persist for the life of a cell lineage. These prope...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1e62145-6277-540e-ae8c-263ae3a18810
- DOI
- 10.1101/840876
